Resveratrol activates MAPK/ERK pathway to regulate oestrogen metabolism in type I endometrial cancer

• Egile Nagusiak: Qing Wang (Egilea), Jia-yun Zhou (Egilea), Li Liu (Egilea), Ze-yuan Yin (Egilea), Yan-yu Li (Egilea), Meng Wang (Egilea), Jing-bo Zhang (Egilea), Hui Lu (Egilea), Xue-yan Zhou (Egilea), Bei Zhang (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2024-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Objective Endometrial cancer (EC) is an oestrogen-dependent tumour, the occurrence of which is closely related to an imbalance of oestrogen homeostasis. Our previous studies explored the effects of Resveratrol(Res) on oestrogen metabolism. However, systematic research on the exact mechanism...